Grey Matters Health Inc · CSE:GREY
Grey Matters Health — Investor Presentation (October 2025)
40 slides from Grey Matters Health's investor presentation, Oct 13, 2025
Slide 1: A Neuroimaging Focused Company – Investor Presentation
A Neuroimaging Focused Company INVESTOR PRESENTATION CSE : GREY | OTCQB : AGNPF | XFRA : AGNW0
Slide 2: Disclaimer
DISCLAIMER Certain statements in this presentation (the “Presentation”) are forward-looking statements, which are made as of the date of this Presentation or as of the date of the effective date of information described in this presentation, as applicable. Forward-looking statements relate to future
Slide 3: Grey Matters Health Capitalization
Grey Matters Health Capitalization Capitalization Common Stock Equivalents NOTE: Not included in the capitalization table above are 7,285,491 Common Warrants (WAEP $1.17), 105,800 Stock Options (WAEP $0.97) and 1,112,167 Preferred Warrants (WAEP $1.90) as all have strike prices well in excess of the
Slide 4: CT Scanner: Computed Tomography (3D Xray)
CT Scanner: Computed Tomography (3D Xray) 4
Slide 5: PET/CT Hybrid Positron Emission Tomography
PET/CT Hybrid Positron Emission Tomography 5
Slide 6: Current Neuroimaging Technology – PET/CT Hybrid
Current Neuroimaging Technology – PET/CT Hybrid Equipment Cost US$3M – US$5M Install (HVAC & Electrical) US$250,000 Lead Shielding US$100,000 Restrictions (Size/Weight) Large Footprint and Heavy - Up to 11,000 lbs. - Ground Floor/Basement Only 6
Slide 7: PET/CT Scanner Overview in U.S.
PET/CT Scanner Overview in U.S. • 50% of scanners are in U.S. hospitals; hard to access • 75% of imaging time is prioritized for cancer diagnostics and theranostics (extensive waiting times - months) • 15% of imaging time is also prioritized for cardiac imaging • Unable to turn off CT scan (not requ
Slide 8: Grey Matters Health Solution
Grey Matters Health Solution 8
Slide 9: The CareMiBrain PET Brain Scanning System
The CareMiBrainTM PET Brain Scanning System 9
Slide 10: NovaScan Neuroimaging Clinics Technology
NovaScan Neuroimaging ClinicsTM Technology • The CareMiBrainTM PET Brain Scanning System • 25% Less Radiation (No CT Scan) • FDA-cleared in 2024: CE Mark for Europe • Ultra Compact (662lbs); high-resolution imaging chair • Standard Wall Outlet Power (115–240V), Low Heat Generation; quiet operation •
Slide 11: Grey Matters Health - Market Vision
Grey Matters Health - Market Vision • Establish a new, national network of private U.S. neuroimaging medical clinics, dedicated to offering FDA-cleared brain specific, neuro optimized PET scanning technology for detection of Alzheimer's Disease, and… - Epilepsy - Parkinson’s - Multiple Sclerosis - B
Slide 12: Diagnosing Alzheimer's Disease with Brain Optimized PET Scans
Diagnosing Alzheimer’s Disease with Brain Optimized PET Scans Capturing a US$6.9 Billion Emerging Market 1 12
Slide 13: Alzheimer's Disease
Alzheimer’s Disease • Alzheimer’s (AD), the most common form of dementia, is a chronic neurodegenerative disease that destroys brain cells • Results in the steady decline over years of a person’s thinking ability and memory • Devastatingly affects an estimated 7 million Americans and 750,000 Canadia
Slide 14: Critical New AD Developments
Critical New AD Developments • Blood tests can now screen for changes in AD biomarkers years before symptoms appear and before irreversible brain damage occurs • The FDA has cleared a new compact brain scanner that confirms plaque presence • The FDA has also approved two new monoclonal antibody trea
Slide 15: Power of Brain PET Scanning
Power of Brain PET Scanning • Positron Emission Tomography (PET) brain scanning is used to confirm a diagnosis of AD • A radioactive tracer is injected into a patient’s bloodstream, which then travels to the brain and binds specifically to beta-amyloid plaques, making them visible on a PET scanner •
Slide 16: New FDA-Approved Monoclonal Antibody Therapies
New FDA-Approved Monoclonal Antibody Therapies Leqembi (Eisai and Biogen) • FDA-Approved 2023 • Given by twice/monthly infusion • US$26,500/year: U.S. Medicare/Medicaid/PI covered Kisunla (Eli Lilly) • FDA-Approved 2024 • Given by monthly infusion • US$32,000/year: U.S. Medicare/Medicaid/PI covered
Slide 17: Milestone PET Scan Announcement
Milestone PET Scan Announcement “A Profound Opportunity.” AKING NEWS BRE GE HealthCare CEO, Peter Arduini ic a re an d M edicaid U.S. Med im it of One ife tim e L Eliminates L er Patient P E T S c a n P Amyloid Brain Note: Comment made in a 2024 GE HealthCare post-earnings call, reflecting on the po
Slide 18: U.S. PET/CT Market
U.S. PET/CT Market • Cumulative Total: BRAIN PET/CT Scans in U.S. (2020-2024) $5.33 billion • Growth Factors: Rising Alzheimer's prevalence (projected 139 million global cases by 2050) and 2023– 2024 Medicare expansions boosted utilization by 20 - 40% in neurology. • New dedicated brain PET devices
Slide 19: First NovaScan Neuroimaging Clinics Location in U.S.
First NovaScan Neuroimaging ClinicsTM Location in U.S. HCA Florida University Medical Office Building, HCA Florida University Hospital Campus 19
Slide 20: HCA Florida University Location
HCA Florida University Location Floor Plan HCA Florida University Medical Office Building Suite 470 7630 SW 34th Manor Davie, Florida 33328 20
Slide 21: Grey Matters Health
y Grey Matters Health. 9,
Slide 22: Grey Matters Health
22 Grey Matters Health.
Slide 23: Grey Matters Health
I Grey Matters Health. 93
Slide 24: Grey Matters Health
yy Grey Matters Health. 94
Slide 25: HCA Florida University Medical Office Building
HCA Florida University Medical Office Building 25
Slide 26: Grey Matters Health
y Grey Matters Health. 9
Slide 27: First NovaScan Neuroimaging Clinics Location in U.S.
First NovaScan Neuroimaging ClinicsTM Location in U.S. ü Board-certified diagnostic radiologist 25 years of experience. ü Undergraduate degree from the University of Florida - medical degree from the University of South Florida Morsani College of Medicine in 1995, ü Board certified by the American B
Slide 28: Geographic Location of First NovaScan Neuroimaging Clinic in U.S.
Geographic Location of First NovaScan Neuroimaging Clinic in U.S. Davie, Florida - 6M People Within One Hour’s Drive 28
Slide 29: Patient Acquisition Targets/Referral Sources
Patient Acquisition Targets/Referral Sources Neurologists 50% Geriatricians 131,434 practicing in the U.S. CRO Psychiatrists General Public General Public 45-65 yrs 25% 104.7 million in the U.S. (Early Screening) PCP 15% Primary Care Physicians 260,687 practicing in the U.S. Specialist Referrals Ref
Slide 30: NovaScan Neuroimaging Clinics Key Metrics
NovaScan Neuroimaging ClinicsTM Key Metrics Square Footage 1,500 – 1,750 Capital Requirements USD $1.1M Includes - US$850 K for Scanner (80% Financed) - US$250 K for Shielding, Furniture, Clinic Equipment/Supplies, Marketing, Working Capital (with fully built-out space) PET Scan Fee (minimum) US$4,5
Slide 31: NovaScan Neuroimaging Clinics Key Metrics
NovaScan Neuroimaging ClinicsTM Key Metrics Staff 2 – Nuclear Medicine Technician/Reception Admin. Monthly Operating Costs (est) US$65 K Daily Maximum # of Scans 15 Annual Maximum # of Scans 3,600 Clinic Break Even 1.6 scans per day 31
Slide 32: U.S. Imaging Company Comparables
U.S. Imaging Company Comparables Public: RadNet, Inc. (NASDAQ: RDNT) is the largest provider of freestanding, fixed-site outpatient diagnostic imaging in the U.S. with more than 400 centers. Market Cap: US$6 B Private: SimonMed Imaging outpatient medical imaging provider operating over 160 locations
Slide 33: NovaScan Neuroimaging Clinics Launch Partners
NovaScan Neuroimaging ClinicsTM Launch Partners Catalyst MedTech • Leading U.S. provider of molecular imaging and nuclear medicine technology to physician practices and healthcare systems • 500 employees with a nationwide presence • Exclusive distributor of the CareMiBrain PET brain specific scanner
Slide 34: NovaScan Neuroimaging Clinics Launch Partners
NovaScan Neuroimaging ClinicsTM Launch Partners ProScan Reading Services • A leading U.S. physician-owned and managed company specializing in teleradiology and services • Extensive Client Base: ProScan provides remote, off-site teleradiology interpretations for approximately 500 medical centers, hos
Slide 35: NovaScan Neuroimaging Clinics Launch Allies
NovaScan Neuroimaging ClinicsTM Launch Allies GE HealthCare Technologies • Leading global health technology company involved in Medical Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. • A significant presence in the distribution space for radiotracers to help facilitate
Slide 36: Corporate Structure
Corporate Structure Grey Matters Health Inc. CSE : GREY | OTCQB : | XFRA : AGNW0 AGNPF Note: - 100% Owned Subsidiary In some U.S. states, where a physician- owned “Professional Corporation” is required to own the clinic, Grey Matters Health will provide management. Holdco LLC Direct Ownership - (Pri
Slide 37: Grey Matters Health Management Team
Grey Matters Health Management Team Christopher J. Moreau James Kinley, CPA CA Chief Executive Officer Chief Financial Officer • President, CEO & director of a TSX:V listed R&D • Mr. Kinley is a Certified Professional Accountant (“CPA, company in the life sciences sector for over nine years CA”) wit
Slide 38: Grey Matters Health Board of Directors
Grey Matters Health Board of Directors Harry Bloomfield Christopher J. Moreau Dr. Raj Attariwala Howard Gutman Dr. Mark Williams KC, MBA CEO & Director MD, PhD, FANM, FRCP Ambassador (Rtd) PhD, MBA Chairman (co-founder of Prenuvo) Director Director Director 38
Slide 39: Key Attributions
Key Attributions 1. https://www.grandviewresearch.com/industry-analysis/us-alzheimers-linked-imaging-market-report 2. https://www.alz.org/alzheimers-dementia/facts-figures 3. https://alzheimer.ca/en/about-dementia/what-dementia/dementia-numbers-canada 4. https://www.ncbi.nlm.nih.gov/books/NBK618297/
Slide 40: Investor Presentation
INVESTOR PRESENTATION CSE : GREY | OTCQB : AGNPF | XFRA : AGNW0
Grey Matters Health — Investor Presentation (October 2025) on 6ix